×
It looks like you're using an obsolete version of internet explorer. Internet explorer is no longer supported by Microsoft since the end of 2015. We invite you to use a newer browser such as Firefox, Google Chrome or Microsoft Edge.

Become an Oncostream member and receive full access to its content!

You must be an Oncostream member to access videos without any restrictions. Register for free in one minute and access all services provided by Oncostream.You will also be able to log into Oncostream from your Facebook or twitter account by clicking on login on the top-right corner of Oncostream website.

Registration Login


Worldwide schedules comment Share

Modérateurs : Dr Caroline Bouche, Dr Jean- Marc Classe & Dr Jean-Sébastien Frénel

Intervenants :
Dr Jean-Sébastien Frénel,
Pr Emmanuel Barranger, Centre Antoine Lacassagne, Nice
Pr Roman Rouzier, Institut Curie, Paris
Dr Jean-Marc Classe, Institut de cancerologie de l'ouest, Nantes

Cas n°1 : Cancer du sein Triple négatif apparemment accessible à une chirurgie première…. Est-ce toujours une bonne idée ?
Dr Jean-Sébastien Frénel
 
Cas n°2 : Cancer du sein T1 RH+/HER2- : quelle indication de chirurgie axillaire en fonction du statut N clinique ?
Pr Emmanuel Barranger
 
Cas n°3 : Cancer du sein RH+/ HER2neg de 4 cm : comment pondérer l’indication de traitement systémique ? Place d’une signature génomique.
Pr Roman Rouzier
 
Cas n°4 : Patiente initialement N0, traitée par CNA : quelle chirurgie axillaire après la CNA ?
Dr Jean-Marc Classe
 

 

 
Shooting date : 2024-05-22
Last update : 2024-06-05

Suggestions

Tuesday, October 15th 2024 from 06pm to 07:30pm (GMT+2)
Honolulu : Tuesday, October 15th 2024 from 07am to 08:30am (GMT+2)
San Francisco : Tuesday, October 15th 2024 from 10am to 11:30am (GMT+2)
New York : Tuesday, October 15th 2024 from 01pm to 02:30pm (GMT+2)
Buenos Aires : Tuesday, October 15th 2024 from 02pm to 03:30pm (GMT+2)
Reykjavik : Tuesday, October 15th 2024 from 05pm to 06:30pm (GMT+2)
London / Dublin : Tuesday, October 15th 2024 from 06pm to 07:30pm (GMT+2)
Paris / Berlin : Tuesday, October 15th 2024 from 07pm to 08:30pm (GMT+2)
Istanbul : Tuesday, October 15th 2024 from 08pm to 09:30pm (GMT+2)
Moscou / Dubaï : Tuesday, October 15th 2024 from 09pm to 10:30pm (GMT+2)
Bangkok : Wednesday, October 16th 2024 from 12am to 01:30am (GMT+2)
Shanghai : Wednesday, October 16th 2024 from 01am to 02:30am (GMT+2)
Tokyo : Wednesday, October 16th 2024 from 02am to 03:30am (GMT+2)
Sydney : Wednesday, October 16th 2024 from 04am to 05:30am (GMT+2)
Wellington : Wednesday, October 16th 2024 from 06am to 07:30am (GMT+2)

Nouveautés dans la détection du ganglion sentinelle du cancer du sein

Share
Tuesday, February 4th 2025 from 06pm to 07:30pm (GMT+1)
Honolulu : Tuesday, February 4th 2025 from 07am to 08:30am (GMT+1)
San Francisco : Tuesday, February 4th 2025 from 09am to 10:30am (GMT+1)
New York : Tuesday, February 4th 2025 from 12pm to 01:30pm (GMT+1)
Buenos Aires : Tuesday, February 4th 2025 from 02pm to 03:30pm (GMT+1)
London / Dublin : Tuesday, February 4th 2025 from 05pm to 06:30pm (GMT+1)
Paris / Berlin : Tuesday, February 4th 2025 from 06pm to 07:30pm (GMT+1)
Istanbul : Tuesday, February 4th 2025 from 07pm to 08:30pm (GMT+1)
Moscou / Dubaï : Tuesday, February 4th 2025 from 09pm to 10:30pm (GMT+1)
Bangkok : Wednesday, February 5th 2025 from 12am to 01:30am (GMT+1)
Shanghai : Wednesday, February 5th 2025 from 01am to 02:30am (GMT+1)
Tokyo : Wednesday, February 5th 2025 from 02am to 03:30am (GMT+1)
Sydney : Wednesday, February 5th 2025 from 03am to 04:30am (GMT+1)
Wellington : Wednesday, February 5th 2025 from 05am to 06:30am (GMT+1)

Prise en charge du cancer du sein métastatique HER2 surexprimé

Share
0
Days
0
Hours
0
Minutes
0
Seconds
Thursday, November 27th 2025 from 07:30pm to 09:30pm (GMT+1)
Honolulu : Thursday, November 27th 2025 from 08:30am to 10:30am (GMT+1)
San Francisco : Thursday, November 27th 2025 from 10:30am to 12:30pm (GMT+1)
New York : Thursday, November 27th 2025 from 01:30pm to 03:30pm (GMT+1)
Buenos Aires : Thursday, November 27th 2025 from 03:30pm to 05:30pm (GMT+1)
London / Dublin : Thursday, November 27th 2025 from 06:30pm to 08:30pm (GMT+1)
Paris / Berlin : Thursday, November 27th 2025 from 07:30pm to 09:30pm (GMT+1)
Istanbul : Thursday, November 27th 2025 from 08:30pm to 10:30pm (GMT+1)
Moscou / Dubaï : Thursday, November 27th 2025 from 10:30pm to 12:30am (GMT+1)
Bangkok : Friday, November 28th 2025 from 01:30am to 03:30am (GMT+1)
Shanghai : Friday, November 28th 2025 from 02:30am to 04:30am (GMT+1)
Tokyo : Friday, November 28th 2025 from 03:30am to 05:30am (GMT+1)
Sydney : Friday, November 28th 2025 from 04:30am to 06:30am (GMT+1)
Wellington : Friday, November 28th 2025 from 06:30am to 08:30am (GMT+1)

Cancers du sein HER2- métastatiques

Que retenir pour la pratique de demain ?

Thursday, October 13th 2022 from 06pm to 07pm (GMT+2)
Honolulu : Thursday, October 13th 2022 from 07am to 08am (GMT+2)
San Francisco : Thursday, October 13th 2022 from 10am to 11am (GMT+2)
New York : Thursday, October 13th 2022 from 01pm to 02pm (GMT+2)
Buenos Aires : Thursday, October 13th 2022 from 02pm to 03pm (GMT+2)
Reykjavik : Thursday, October 13th 2022 from 05pm to 06pm (GMT+2)
London / Dublin : Thursday, October 13th 2022 from 06pm to 07pm (GMT+2)
Paris / Berlin : Thursday, October 13th 2022 from 07pm to 08pm (GMT+2)
Istanbul : Thursday, October 13th 2022 from 08pm to 09pm (GMT+2)
Moscou / Dubaï : Thursday, October 13th 2022 from 09pm to 10pm (GMT+2)
Bangkok : Friday, October 14th 2022 from 12am to 01am (GMT+2)
Shanghai : Friday, October 14th 2022 from 01am to 02am (GMT+2)
Tokyo : Friday, October 14th 2022 from 02am to 03am (GMT+2)
Sydney : Friday, October 14th 2022 from 04am to 05am (GMT+2)
Wellington : Friday, October 14th 2022 from 06am to 07am (GMT+2)

Les inhibiteurs de tyrosine kinase (TKI) et les anticorps conjugués (ADC) dans le cancer du sein mÃ...

Les nouveaux traitements, entre choix et complémentarité

Share
Scroll Up